BeStock  
Stocks › Biotechnology › INBX

Inhibrx Biosciences INBX

US equityMarket cap rank #3034Biotechnology
$94.56 −$2.43 (-2.51%)
Pre-market · Oct 6, 4:10 am ET · After hours $95.69 +1.20%
Open$97.56
Prev close$96.99
Day range$94.18 – $98.51
Volume207.1K
Market cap$1.39B
P/E (TTM)–
Dividend yield–

Analyst view

ConsensusBuy
Analysts3
Average target$266.67+182.0% vs. price
  • Buy 100%
Low $230.00Now $94.56Avg $266.67High $325.00

Recent rating changes

The last 14 actions on file set price targets from $150.00 to $325.00, averaging $254.29.

DateFirmRatingTarget
9 Sep 2026 H.C. Wainwright BUY $245.00
8 Sep 2026 LifeSci Capital BUY $230.00
24 Aug 2026 H.C. Wainwright BUY $245.00
21 Aug 2026 Stifel BUY $325.00
14 Aug 2026 LifeSci Capital BUY $230.00
14 Aug 2026 Stifel BUY $325.00
2 Jun 2026 Stifel BUY $325.00
16 May 2026 LifeSci Capital BUY $230.00
15 May 2026 Stifel BUY $325.00
11 May 2026 LifeSci Capital BUY $230.00
25 Apr 2026 LifeSci Capital BUY $200.00
24 Apr 2026 LifeSci Capital BUY $200.00
22 Apr 2026 Stifel BUY $300.00
17 Apr 2026 Stifel BUY $150.00

Discussion

No comments yet — be the first to weigh in on INBX.

Leave a comment

Scroll to Top